Oncologists’ meetings with drug reps don’t help cancer patients live longer

Drug companies often do one-on-one outreach to doctors. A new study finds these meetings with drug reps lead to more prescriptions for cancer patients, but not longer survival.

Drug company reps commonly visit doctors to talk about new medications. A team of economists wanted to know if that helps patients live longer. They found that for cancer patients, the answer is no.

(Image credit: Chris Hondros)

Read the full post on NPR Topics: Health Care

Sydney Lupkin